Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial
Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share up to USD$1.48 early on in the trading day. Solid Liquidity Position The company reported a stellar liquidity position at the end of the fourth quarter of fiscal 2021, with cash […]
Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?
Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment Partners. MX stock price saw an uptrend of 11.31% a share at the time of this writing. MX stock closed previously with a $23.05 per share price. Let’s deep dive to […]
Why is Autolus Therapeutics plc (AUTL) stock rising today?
Shares of Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel in r/r Indolent B Cell Lymphomas and update of obe-cel in r/r Adult ALL by Autolus Therapeutics at European Hematology Association Virtual Congress. The AUTL stock price saw a push of […]
Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.
Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on June 11, 2021, after which the MBIO stock price saw a push of 5.25% to reach $4.01 a share at the time of this writing. The last trading session was favorable […]
Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?
Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by 5.9% in the pre-market trading session. ProPhase Labs is a medical technology and scientific firm with a wide range of products. At its CLIA-certified laboratories, PRPH’s subsidiary, ProPhase Diagnostics, provides a […]
Vertex Pharmaceuticals Inc. (VRTX) stock plunged during after-hour. Here’s what you should know
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) stock gained by 1.5% at last close while the VRTX stock price declines during after-hour by 12.95%. Vertex is a multinational biotechnology business that invests in scientific research to develop life-changing treatments for patients suffering from critical illnesses. Multiple drugs approved by VRTX treat the underlying cause of cystic fibrosis […]
